Please Wait a Moment
X

Articles

16Jul

CTS implements Ultrio Plus on the Panther

16 Jul, 2020 | Return|
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA testing and has been approved by the US FDA for WNV, ZIKA, and now Ultrio Elite testing.
 
The Procleix Panther instrument with its automated process will allow the CTS laboratories to operate with increased efficiencies with processing all three assays (WNV, ZIKA, Ultrio Elite) using a single pooled or individual donation sample. We expect less downtime and fewer NAT assay failures.
 
On Tuesday, July 7, 2020 CTS Phoenix and Tampa converted from Tigris Ultrio Plus to Panther Ultrio Elite. Our Charlotte, Dallas, and St. Louis labs implemented on July 13th.

Related

CTS Implements HLA Class I and II Testing on the Gemini

CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...

Read More >

Discontinue HIV-1 IFA Confirmatory Test

CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...

Read More >

National Blood Donor Month

National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...

Read More >

Reminder- Health and Human Services (HHS) email notifications for WNV reactives

Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...

Read More >

The Reentry Changes Q & A document is now available

The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...

Read More >

CTS Tampa Implementation date change for Ultrio Elite

CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...

Read More >